Angelo Auricchio

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

Angelo Auricchio has coordinated or participated in the 92 publications here listed (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations)

1) Validation of Utstein-Based score to predict return of spontaneous circulation (UB-ROSC) in patients with out-of-hospital cardiac arrest

2) Editorial

3) Deep Generative Models: The winning key for large and easily accessible ECG datasets?

4) Perceived threats and challenges experienced by first responders during their mission for an out-of-hospital cardiac arrest

5) Fewer worsening heart failure events with HeartLogicTM on top of standard of care: a propensity-matched cohort analysis

6) Association Between Postresuscitation 12-Lead ECG Features and Early Mortality After Out-of-Hospital Cardiac Arrest: A Post Hoc Subanalysis of the PEACE Study

7) Effects of Atrioventricular Optimization on Left Ventricular Reverse Remodeling With Cardiac Resynchronization Therapy: Results of the SMART-CRT Trial

8) Proposal to increase safety of first responders dispatched to cardiac arrest

9) Genetics in Probands With Idiopathic Ventricular Fibrillation: A Multicenter Study

10) Activation time at the left ventricular pacing site (QLV) relative to the actual site of latest activation-Implications for response to cardiac resynchronization therapy

11) Impact of sex and role of coronary artery disease in out-of-hospital cardiac arrest presenting with refractory ventricular arrhythmias

12) Use of Contemporary Imaging Techniques for Electrophysiological and Device Implantation Procedures

13) What is this image? 2023 image 5 result: Role of 18-Fluorodeoxyglucose positron emission tomography and computed tomography in cardiac implanted electronic device infection

14) Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients

15) Worldwide Survey of COVID-19-Associated Arrhythmias

16) Insulin-like growth factor-binding protein 7 and risk of congestive heart failure hospitalization in patients with atrial fibrillation

17) Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders, previously untreatable and high-risk upgrade patients (SOLVE-CRT) trial

18) Estimating Left Ventricular Electrical Delay From the Right Ventricular Lead Electrogram

19) Right ventricular outflow tract electroanatomical abnormalities in asymptomatic and high-risk symptomatic patients with Brugada syndrome: Evidence for a new risk stratification tool?

20) More patients could benefit from dispatch of citizen first responders to cardiac arrests

21) Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey

22) CRT Efficacy in "Mid-Range" QRS Duration Among Asians Contrasted to Non-Asians, and Influence of Height

23) Machine learning-derived major adverse event prediction of patients undergoing transvenous lead extraction: Using the ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry

24) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC)

25) Synchronization of repolarization after cardiac resynchronization therapy: A combined clinical and modeling study

26) Status and Update on Cardiac Resynchronization Therapy Trials

27) [2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European _ ita

28) End-tidal carbon dioxide (ETCO2) at intubation and its increase after 10 minutes resuscitation predicts survival with good neurological outcome in out-of-hospital cardiac arrest patients

29) Antitachycardia pacing success in implantable cardioverter-defibrillators by patient, device, and programming characteristics

30) Family History of Sudden Cardiac Death in the Young and Inherited Arrhythmia Syndromes: Awareness and Attitudes of General Practitioners and Private Practice Cardiologists

31) Optimisation of cardiac resynchronisation therapy device selection guided by cardiac magnetic resonance imaging: Cost-effectiveness analysis

32) Leadless left ventricular endocardial pacing in nonresponders to conventional cardiac resynchronization therapy

33) Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy

34) Plasma Extracellular Vesicles as Liquid Biopsy to Unravel the Molecular Mechanisms of Cardiac Reverse Remodeling Following Resynchronization Therapy?

35) Utilization of remote monitoring among patients receiving cardiac resynchronization therapy and comparison between Asia and the Americas

36) Reply to the Editor-Programming more ATP sequences is not a case of no harm, no foul

37) Role of genetic testing in young patients with idiopathic atrioventricular conduction disease

38) Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort

39) Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing

40) Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation

41) Long-Term Outcomes of Pulmonary Vein Isolation in Patients With Brugada Syndrome and Paroxysmal Atrial Fibrillation

42) Association between ventricular repolarization parameters and cardiovascular death in patients of the SWISS-AF cohort

43) Electrical management of heart failure: from pathophysiology to treatment

44) Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study

45) Lead fixation mechanism impacts outcome of transvenous lead extraction: data from the European Lead Extraction ConTRolled Registry

46) Corrigendum to: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC)

47) Right Hemispheric Predominance of Brain Infarcts in Atrial Fibrillation: A Lesion Mapping Analysis

48) Catheter Ablation of Atrial Fibrillation in Patients with Previous Lobectomy or Partial Lung Resection: Long-Term Results of an International Multicenter Study

49) Extended ECG Improves Classification of Paroxysmal and Persistent Atrial Fibrillation Based on P- and f-Waves

50) Performance evaluation of implantable cardioverter-defibrillators with SmartShock technology in patients with inherited arrhythmogenic diseases

51) Silent brain infarcts impact on cognitive function in atrial fibrillation

52) Perioperative Management of Patients with Cardiac Implantable Electronic Devices and Utility of Magnet Application

53) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 2

54) Filamin C missense variant associated with severe right atrial disease and skeletal myopathy

55) Long-term outcome of catheter ablation for atrial fibrillation in patients with severe left atrial enlargement and reduced left ventricular ejection fraction

56) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

57) Leadless left ventricular endocardial pacing for CRT upgrades in previously failed and high-risk patients in comparison with coronary sinus CRT upgrades

58) A quantitative assessment of the contribution of "citizen First Responder" in the adult out-of-hospital chain of survival during COVID-19 pandemic

59) Swiss National Registry on Catheter Ablation Procedures: Changing Trends over the Last 20 Years

60) The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy

61) Patient voluntarily delays call to emergency medical system for ST-elevation myocardial infarction during COVID-19 pandemic

62) Heart rate and adverse outcomes in patients with prevalent atrial fibrillation

63) EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators ...

64) The effect of centre volume and procedure location on major complications and mortality from transvenous lead extraction: an ESC EHRA EORP European Lead Extraction ConTRolled ELECTRa Registry subanalysis-Author’s reply

65) Automatic reconstruction of the left atrium activation from sparse intracardiac contact recordings by inverse estimate of fibre structure and anisotropic conduction in a patient-specific model

66) Synergistic antiarrhythmic effect of inward rectifier current inhibition and pulmonary vein isolation in a 3D computer model for atrial fibrillation

67) Out-of-hospital cardiac arrests and mortality in Swiss Cantons with high and low COVID-19 incidence: A nationwide analysis

68) A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)

69) Risk stratification of patients undergoing transvenous lead extraction with the ELECTRa Registry Outcome Score (EROS): an ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry analysis

70) Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients

71) False positive ECG for STEMI after ROSC, is it a matter of timing?

72) Modified Design of Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-responders, Previously Untreatable and High-Risk Upgrade Patients (SOLVE-CRT) Trial

73) Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care

74) Short P-Wave Duration is a Marker of Higher Rate of Atrial Fibrillation Recurrences after Pulmonary Vein Isolation: New Insights into the Pathophysiological Mechanisms Through Computer Simulations

75) Association of Timing of Electrocardiogram Acquisition After Return of Spontaneous Circulation With Coronary Angiography Findings in Patients With Out-of-Hospital Cardiac Arrest

76) Left Atrial Appendage Electrical Isolation Reduces Atrial Fibrillation Recurrences: A Simulation Study

77) Electrocardiographic Predictors of Successful Resynchronization of Left Bundle Branch Block by His Bundle Pacing

78) Challenges in activation of remote monitoring in patients with cardiac rhythm devices during the coronavirus (COVID-19) pandemic

Angelo Auricchio has coordinated or participated in the 92 publications here listed
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations)